European Medicines Regulatory Network
GPTKB entity
Statements (70)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Regulatory network
|
| gptkbp:aimsTo |
Regulatory frameworks
Collaboration among stakeholders Health outcomes Patient information Promote public health Patient access to treatments Access to innovative therapies Access to safe medicines Ensure the safety of medicines Equitable access to medicines Medicinal product shortages Public awareness of medicines safety Trust in regulatory processes |
| gptkbp:communicationEquipment |
Healthcare_professionals
|
| gptkbp:contributedTo |
Harmonization of regulations
|
| gptkbp:coordinates |
Post-marketing surveillance
|
| gptkbp:developedBy |
Regulatory assessments
Risk management plans |
| gptkbp:develops |
Common standards for medicines
|
| gptkbp:developsStrategiesFor |
Access to medicines
|
| gptkbp:encourages |
Collaboration among member states
|
| gptkbp:engagesIn |
Stakeholders in healthcare
|
| gptkbp:enhances |
Market access for medicines
|
| gptkbp:facilitates |
Regulatory cooperation
|
| gptkbp:hasMember |
gptkb:European_Medicines_Agency
National_Competent_Authorities |
| https://www.w3.org/2000/01/rdf-schema#label |
European Medicines Regulatory Network
|
| gptkbp:isEngagedIn |
Public consultations
|
| gptkbp:isFocusedOn |
Patient safety
|
| gptkbp:isGovernedBy |
gptkb:European_Commission
|
| gptkbp:isInvolvedIn |
Regulatory compliance
Patient safety initiatives Public health emergencies Health technology assessment Regulatory science Collaboration with academia Patient engagement activities Drug approval processes Regulatory impact assessments Collaboration with industry stakeholders Regulatory training programs Pharmacovigilance activities Ethical review of clinical trials Monitoring of adverse drug reactions Quality assurance of medicines Regulatory framework assessments Regulatory harmonization efforts Regulatory policy development Risk assessment of medicines |
| gptkbp:isPartOf |
Global health initiatives
European_health_policy |
| gptkbp:isSupportedBy |
gptkb:European_Medicines_Agency
Scientific committees |
| gptkbp:operatesIn |
gptkb:European_Union
|
| gptkbp:promotes |
Sustainable healthcare solutions
Transparency in regulatory processes |
| gptkbp:provides |
Guidelines for medicine approval
|
| gptkbp:providesAccessTo |
Clinical trial data
|
| gptkbp:providesGuidanceOn |
Clinical trial applications
Regulatory submissions. |
| gptkbp:providesSupportFor |
Member states' regulatory activities
Research and development of medicines |
| gptkbp:providesTrainingFor |
Regulatory professionals
|
| gptkbp:supports |
Data sharing initiatives
Drug safety Innovation in drug development Pharmaceutical innovation Capacity building in member states |
| gptkbp:worksWith |
International regulatory bodies
|